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Abstract  
Antimicrobial resistance is now widely acknowledged as a major global public health 
challenge. There are many environments through which the transmission and diffusion of 
antibiotic resistance could happen, but one of the main routes of transmission is the food 
chain. As a matter of fact, antibiotic use is widely spread in animal husbandry and in 
agriculture. In particular, in animal husbandry antimicrobials have been used both for 
therapeutic reasons and as growth promoters. As a consequence, a selective pressure on 
pathogenic and commensal bacteria of animal origin has been exerted during the time, leading 
to the onset of microorganisms resistant to such compounds. A pivotal role in the spread in 
the food chain of antibiotic resistance has been played by non-pathogenic bacteria present in 
food. These microorganisms are not harmful for humans, but they could represent a reservoir 
of antibiotic resistance for foodborne pathogenic bacteria. Usually lactic acid bacteria play 
this role, since they are present in all fermented food. For this reason, the antibiotic resistance 
profile of lactic acid bacteria has been assessed. 
In recent years, another class of microorganisms, called halophilic archaea, has raised an 
increasing scientific interest, since they have been found in the human intestinal mucosa as 
well as in foods such as salted codfish and fermented Asiatic seafood. 
As a few papers have studied the antibiotic resistance profiles of halophilic archaea, and the 
only present do not consider a statistically significant number of microorganisms belonging to 
the same species, the aim of the present work is to define the antibiotic resistance profile of 
the major exponent of halophilic archaea, named Halobacterium salinarum, and consequently 
to verify if some strains present antibiotic resistances and if they can transfer these resistances 
to bacteria present in the food chain. 
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General Introduction 
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Antibiotic resistance problem  
Since their discovery, antibiotics and antimicrobial drugs have led to an important decrease in 
deaths from infectious diseases, and have contributed to the extension in life expectancy 
experienced during the latter part of the last century (Armstrong et al., 1999).  
The use of antibiotics for any purpose – in people, animals, plants – anywhere in the world 
affects everyone. As a consequence, the widespread use of antimicrobial substances has led to 
resistant populations of microorganisms in several ecosystems. In animal husbandry, for 
instance, antimicrobials have been used both for therapeutic reasons and as growth promoters, 
but both of these uses will provide a selective pressure on pathogenic and commensal bacteria 
of animal origin (Mayrhofer et al., 2007; Teale, 2002). As a matter of fact antibiotic use in 
one individual can promote the local survival of resistant strains that can subsequently spread 
from that individual to others and potentially, over time, to any community worldwide. 
In recent decades, the emergence and spread of antibiotic-resistant microbes have challenged 
clinicians and researchers. At present, antibiotic resistance is a global public health threat that 
involves all major microbial pathogens and antimicrobial drugs, affecting current and future 
generations (Capita and Alonso-Calleja, 2013). 
At word level, the World Health Organisation (WHO) has the mission of building a better, 
healthier future for people all over the world. For this reason, tackling antibiotic resistance is 
becoming a high priority for the WHO. A proof of this interest is that at the World Health 
Assembly in May 2015 a global action plan on antimicrobial resistance, including antibiotic 
resistance, was endorsed. The principal aim of this plan is to ensure prevention and treatment 
of infectious diseases with safe and effective medicines. This plan contemplates five strategic 
objectives: 
1. To improve awareness and understanding of antimicrobial resistance. 
2. To strengthen surveillance and research. 
3. To reduce the incidence of infection. 
4. To optimize the use of antimicrobial medicines. 
5. To ensure sustainable investment in countering antimicrobial resistance. 
Furthermore at the United Nations General Assembly in New York in September 2016 the 
Heads of State committed to address the fundamental causes of antimicrobial resistance 
across multiple sectors, especially human health, animal health and agriculture by taking a 
broad coordinated approach. Countries, supported by the WHO, reaffirmed their dedication to 
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develop national action plans on antimicrobial resistance, based on the global action plan 
(http://www.who.int/en/). 
In America the Centers for Disease Control and Prevention (CDC) is monitoring the situation 
of the antibiotic resistance threats in the United States. Recent reports state that each year in 
the United States, at least 2 million people become infected with bacteria that are resistant to 
antibiotics and at least 23,000 people die each year as a direct result of these infections. Many 
more people die from other conditions that were complicated by an antibiotic-resistant 
infection. 
Moreover, data show that antibiotic-resistant infections can happen anywhere. In particular, 
the majority happen in the general community; however, most deaths related to antibiotic 
resistance can be found in healthcare settings such as hospitals and nursing homes 
(https://www.cdc.gov/). 
 
Antimicrobials of human and veterinary importance: the European Union 
approach 
The European Food Safety Authority (EFSA) is the European Union risk assessor and the 
provider of independent scientific advice and communication on risks associated with the 
food chain. One of its tasks is to provide a method to identify resistance to antimicrobials of 
human and veterinary importance in bacterial strains intended for use as feed additives (Efsa 
and Efsa FEEDAP, 2012). All these antibiotics with some resistance genes are listed in Table 
1.  
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Table 1. Classes of antimicrobials, examples of substances used in human and veterinary medicine and examples of resistance genes (Andreoletti et al., 2008). 
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Antibiotic use in food production 
As mentioned above, antibiotics are used, as regards the agri-food sector, in animals for 
therapy, disease prevention and, even if not in Europe, also for growth promotion. The classes 
of antibiotics used in animals are the same of those used in people. However, because of the 
large number of animals and the industrialized production of food animals, the quantity of 
antibiotics used in food production in many countries seems to exceed the amounts used 
medicinally in people infections (World Health Organisation, 2011).  
Food animals are treated with antibiotics when affected by respiratory and enteric infections 
and especially during the early part of an animal’s life. Antibiotics are also used to treat 
infections in individual animals caused by a variety of bacterial pathogens. In particular, 
antibiotics are often used in dairy cows for treating mastitis and in cows with a high milk 
output to handle common infections (World Health Organisation, 2011). 
Furthermore, antibiotics are used also in fish farming. The intensification in this sector has 
been accompanied by bacterial infections that are usually treated with antibiotics added to fish 
foodstuffs. Similar to other industrialized food animal production, the usage of antibiotics in 
aquaculture can be significant. 
Another field where antibiotics are used is agriculture. The number of antibiotics used in plant 
agriculture is modest relative to applications in human and veterinary medicine and in animal 
production. The most used are streptomycin, gentamycin, oxytetracycline, oxolinic acid. As a 
consequence, bacteria affecting plants have become resistant to streptomycin and tetracycline. 
How much the antibiotic use in agriculture contributes to the development of antibiotic 
resistance in human pathogens is still a debated issue (McManus et al., 2002). 
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Potential routes of transmission of antimicrobial resistance in the food chain 
Generally, undercooked and raw consumed vegetables and fruit are the most prone food to 
contain high levels of bacteria, including antimicrobial-resistant bacteria, derived from 
primary production (Faour-Klingbeil et al., 2016; Losio et al., 2015; Rosenquist et al., 2005). 
Cooking or other microbicidal treatments (such as high pressure processing) reduce bacteria 
loads, but if intact DNA coding for resistance is present, it may persist in such treated food 
(Andreoletti et al., 2008). In addition to primary production, there are a number of processing 
steps as storage, preparation and serving, which can contaminate the final product (Figure 1). 
 
 
Figure 1. Schematic view of possible routes of transmission of antibiotic resistance via food 
(Andreoletti et al., 2008). 
 
The role of non-pathogenic food related bacteria 
It is estimated that approximately one-quarter of food production involves microbial 
fermentation processes, primarily lactic acid bacteria (LAB). Since it is known that horizontal 
transfer of antibiotic resistance genes may take place in the environment, including food and 
the gastrointestinal tract, there has been the necessity of assessing the safety of bacteria use in 
food production to antibiotics of human and veterinary importance. 
Whereas microorganisms may theoretically transfer antimicrobial resistant genes to 
pathogens, antimicrobial resistance might be considered as one criterion to assess the safety of 
strains used in food and feed (Borriello et al., 2003). 
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In this scenario, a pivotal role was played by the project “Assessment and Critical Evaluation 
of Antibiotic Resistance Transferability in Food Chain” (ACE-ART) that was aimed at 
providing a critical evaluation of the impact of antibiotic use in agriculture and in the 
prophylaxis and treatment of disease in humans on non-pathogenic, food-related bacteria.  
The ACE-ART consortium implemented a diffused promotion, targeting both the European 
authorities and the greater public, and at the same time encouraged cooperation between 
scientists and industries. Thanks to ACE-ART, some non-pathogenic, food related bacteria, 
mainly lactic acid bacteria, have been identified as reservoir of drug resistances, which can be 
transferred to pathogens with important consequences for the food industry and for future 
preventive and management strategies. Moreover, in the frame of this project the 
methodology for assessing minimal inhibitory concentrations in bifidobacteria and non-
enterococcal lactic acid bacteria was developed (ISO 10932/IDF 223).   
As a consequence, the food chain has been considered one of the major routes of antibiotic 
resistance spread.  
 
Antibiotic resistance mechanisms among bacteria  
There are two kinds of antibiotic resistance in a microorganism: when resistance to an 
antimicrobial is inherent to a bacterial species, it is generally referred to as “intrinsic 
resistance” (sometimes called “natural resistance”) and is typical of all the strains of that 
species. In other cases, susceptible bacteria have become resistant over the course of the last 
several decades: in this case we can talk about “acquired resistance” (World Health 
Organisation, 2011). The major mechanisms of antimicrobial resistance that have been 
described are three: direct inactivation of the active molecule, loss of bacterial susceptibility 
to the antimicrobial by modification of the target of action, and decreased amount of drug that 
reaches the target molecule without modification of the compound itself (Bories et al., 2008). 
 
Intrinsic resistance 
As suggested by the name, intrinsic resistance is due to a natural feature of a microorganism. 
The antibiotic defence mechanisms of intrinsic resistance are, in most cases, related to the 
presence of low affinity targets, the absence of targets, decreased uptake or efflux of drugs 
(Bories et al., 2008).  
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Acquired resistance 
Acquired resistance can be achieved by the mutation of genes already present in the bacterial 
genome or by the acquisition of genes via gain of exogenous DNA.  
Generally a simple mutation causes the modification of the target of the antibiotic, resulting in 
a less affinity of the compound (Flensburg and Skold, 1984) or the overproduction of intrinsic 
resistance determinants, such as efflux pumps (Beinlich et al., 2001). When a bacterium 
becomes resistant to an antibiotic through a novel mutation in its DNA, the only way of 
spreading this resistance is proliferation of the bacterium itself (vertical transfer).  
On the other hand, the three routes of acquiring exogenous DNA are: transformation, 
transduction and conjugation (Figure 2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Acquisition of antibiotic resistance by bacteria. Ab
r
 stands for antibiotic resistance 
(Alekshun and Levy, 2007). 
 
Transformation is the direct uptake and incorporation of exogenous genetic material from the 
environment through the cell membrane. Conjugation is the process through which bacteria 
exchange their genetic material. During transduction foreign DNA is introduced into a cell by 
a virus or viral vector (Alberts et al., 2002). Both transformation and conjugation can be 
ascribed as horizontal gene transfer. 
Horizontal gene transfer can lead to the acquisition of new genes as a result of gene exchange 
between bacteria. These newly acquired genes can code for enzymes that modify the drug, 
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inactivating it, such as β-lactamases or acetyl transferases (Poole, 2002), or can code for 
mechanisms of decreased susceptibility to antimicrobials due to target modification. 
The consequences of horizontal gene transfer are more serious than the ones of vertical 
transfer. The former mechanism can often promote the simultaneous spread of resistance to 
several unrelated classes of antibiotics, particularly if the genes for such resistance are co-
located on the transmissible genetic element.  
To make matters worse, sometimes genes for resistance and virulence can be transferred 
together, leading to the emergence of new resistance threats of greater virulence and 
pathogenicity than seen in past generations.  
 
Alteration of the target 
Alteration of target sites of antibiotics is a common mechanism of resistance. This is because 
generally the targets of antibiotics have vital roles in the life of a microorganisms, and the 
interference with them leads to cell death or growth inhibition. The targets preferred by 
antibiotics are: protein synthesis (aminoglycosides, tetracyclines, macrolides, 
chloramphenicol, fusidic acid, mupirocin, streptogramins, oxazolidinones), transcription via 
RNA polymerase (the rifamycins); chromosome segregation (quinolones) and integrity 
(metronidazole); and folic acid metabolism (trimethoprim, pyrimethamine) (Lambert, 2005). 
Generally target alteration is the result of a point mutation in the nucleotide sequence that 
codifies for it, which results in the transcription of a different mRNA sequence that is 
translated in a different protein that shows a less affinity with the antibiotic which binds to. 
 
Drug inactivating enzymes 
Antibiotic inactivation includes hydrolysis, group transfer, and redox mechanisms. The most 
widespread modifications are listed in Table 2.  
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Table 2. Enzymatic strategies of antibiotic inactivation (Wright, 2005). 
Strategy Type Antibiotics affected 
   
Hydrolysis  β-Lactams 
Macrolides 
   
Group transfer Acyl Aminoglycoside 
Chloramphenicol 
Type A Streptogramin 
   
 Phosphoryl Aminoglycoside 
Macrolide 
Rifamycin 
Peptide 
   
 Thiol Fosfomycin 
  
Nucleotidyl 
 
Aminoglycoside 
Lincosamide 
   
 ADP-ribosyl Rifamycin 
  
Glycosyl 
 
Macrolide 
Rifamycin 
 
 
Other 
 
Redox 
 
 
 
Lyase 
 
 
Tetracycline 
Rifamycin 
Type A streptogramin 
 
Type B streptogramin 
 
 
Hydrolysis 
Many antibiotics present chemical bonds that are sensible to hydrolysis, such as esters and 
amides. For this reason bacteria have evolved a mechanism of resistance that involves the 
cleavage of these bonds. 
Among the enzymes that hydrolyse drugs there are: β-lactamases, macrolide esterases and 
epoxidases.  
β-lactamases have one common property of catalysing the hydrolysis of the β-lactam ring of 
penicillins and cephalosporins. It is interesting that although  β-lactam antibiotics present 
various killing targets (penicillin binding proteins), they are inactivated by only one enzyme. 
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However, a wide range of bacteria produces this enzyme, presenting different chemical, 
physical and enzymological properties (Ogawara, 1981). 
The macrolide esterases EreA (Ounissi and Courvalin, 1985) and EreB (Arthur et al., 1986) 
inactivate drugs through the hydrolysis of the macrolactone ring. EreA has been found in 
Gram-negative bacteria while EreB is thought to originate from Gram-positive organisms on 
the basis of GC content analysis (Morar et al., 2012). Albeit the most common macrolide 
resistance mechanism is constituted by modifications of the ribosome, resistance via esterase 
activity has been increased among clinical isolates worldwide (Nakamura et al., 2000; Yong 
et al., 2009). 
One of the most known epoxidases that act against an epoxide antibiotic is FosX. In 
particular, it inhibits the antibiotic fosfomycin, which interacts with MurA, the enzyme that 
catalyses the first committed step in peptidoglycan biosynthesis. FosX action consists on the 
destruction of the reactive epoxide by ring opening by either a thiol-containing co-substrate 
(Wright, 2005). 
 
Group transfer 
A very large family of resistance enzymes is the group of transferases. These enzymes 
covalently modify antibiotics resulting in structural alterations that impair target binding. 
Each of these enzymes takes the name from the group they transfer (Wright, 2005).  
One of the most common mechanisms of antibiotic inactivation employed by bacteria is 
acyltransfer, and specifically acetyltransfer. It consists on the covalent modification of 
vulnerable hydroxyl and/or amine groups on antibiotics, which results in compounds that lose 
their ability to bind target and, therefore, become inactive. Among this class the most well 
characterized are: aminoglycoside acetyltransferases (Wybenga-Groot et al., 1999), 
chloramphenicol acetyltransferases (Leslie et al., 1988) and streptogramin acetyltransferases 
(Sugantino and Roderick, 2002).  
Kinases are a group of enzymes that catalyses the transfer of phosphate groups from high-
energy, phosphate-donating molecules (usually ATP) to specific substrates. The known 
antibiotic kinases involved in resistance are exclusively O-phospho- transferases, and many 
share structural and mechanistic details with other kinases such as the protein kinases. 
Antibiotics that are known to present kinases specific for them are: aminoglycosides (Ramirez 
and Tolmasky, 2010), macrolides (Noguchi et al., 1995), rifamycins (Morisaki et al., 1993) 
and peptide antibiotics (Skinner and Cundliffe, 1980). 
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FosB is a Mg
2+
-dependent cysteine thiol transferase. It acts on fosfomycin like the 
aforementioned FosX, by adding l-cysteine to this antibiotic, with a resulted inhibition (Cao et 
al., 2001).  
There are two major classes of nucleotidyltransferases: the ANTs that modify 
aminoglycosides, and the Lin proteins that inactivate the lincosamide antibiotics such as 
lincomycin and clindamycin. Their action is to transfer the nucleoside monophosphate group 
of a nucleotide to the target antibiotic (Bacot-Davis et al., 2016). 
ADP-ribosyl transfer is a common mechanism of protein modification in both eukaryotes and 
prokaryotes. These modifications occur on amino acid residues and require nicotinamide 
adenine dinucleotide (NAD) as the ADP-ribosyl donor. Although well established as a protein 
modification mechanism of significant importance, small molecule ADP-ribosylation is 
unknown with one exception: a reported ADP-ribosylation of the antibiotic rifampin that 
results in resistance in bacterial pathogens (Quan et al., 1997). 
In the group of transferases, glycosylases are the less widespread. They play a role in the 
protection of microorganisms producing antibiotic, in particular against macrolides and 
rifamycin (Wright, 2005). 
 
Redox enzymes and lyases  
Other mechanisms of resistance are less common than the previously described. These include 
redox and lyase enzymes. TetX is a well-studied example among the redox enzymes. It is a 
flavin-dependent monooxygenase that regioselectively hydroxylates the tetracycline substrate, 
resulting in an unstable compound that undergoes non-enzymatic decomposition (Yang et al., 
2004). Whereas Vgb is a lyase that inactivate type B streptogramins. This enzyme linearizes 
the antibiotic by an elimination reaction (Mukhtar et al., 2001). 
 
Efflux mechanisms 
Proteins involved in drug transport 
Almost all bacteria species present efflux pumps, and genes encoding for these proteins are 
located on chromosomes or plasmids (Piddock, 2006; Poole, 2004). Bacterial efflux pumps 
can be classified into five families, which differ in composition, number of transmembrane 
spanning regions, energy source and substrate. The families are the following: the resistance-
nodulation-division (RND) family, the major facilitator superfamily (MFS), the ATP 
(adenosine triphosphate)-binding cassette (ABC) superfamily, the small multidrug resistance 
(SMR) family, which is a member of the much larger drug/metabolite transporter (DMT) 
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superfamily, and the multidrug and toxic compound extrusion (MATE) family (Piddock, 
2006; Poole, 2004; Putman et al., 2000) (Figure 3). 
 
Figure 3. Schematic representation of the major families of Multi-Drug Resistance (MDR) 
transporters in prokaryotes. OM is outer membrane and CM is cytoplasmic membrane (Lubelski et al., 
2007).  
 
ABC and MFS superfamilies are very large and ancient (Higgins, 2001; Pao et al., 1998), 
while MATE, SMR and RND are smaller families (Brown et al., 1999; Paulsen et al., 1996). 
All these families are widely distributed in Gram positive and negative bacteria, except for 
RND superfamily that is only found in Gram negative bacteria (Handzlik et al., 2013).  
According to the specific class they belong to, efflux pumps can be constituted by a single-
component transporter or multiple-component systems containing not only an inner 
membrane transporter, but also an outer membrane channel and a periplasmic adaptor protein, 
such as the RND type efflux pumps (Li and Nikaido, 2004). In the following paragraphs we 
will see the peculiarity of each of these families. 
 
RND family 
The resistance-nodulation-cell-division (RND) superfamily of solute transporters consists of a 
large periplasmic domain that assembles with periplasmic fusion proteins and an outer 
membrane pore to form a complete tripartite channel from the inner cytoplasm past the outer 
membrane in Gram-negative bacteria (Li and Nikaido, 2004). This family of membrane 
proteins uses a proton antiport for transporting substances and it is capable of extruding 
completely harmful substances from the bacterial cell (Nikaido and Takatsuka, 2009). 
Multidrug recognition is based on a multisite drug-binding mechanism, in which two 
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voluminous multidrug-binding pockets in cell membrane exporters recognize a wide range of 
substrates as a result of permutations at numerous binding sites that are specific for the partial 
structures of substrate molecules. The voluminous multidrug-binding pocket may have 
numerous binding sites, seven for a single substrate, suggesting that substrates may move 
between binding sites during transport, an idea named as multisite-drug-oscillation hypothesis 
(Yamaguchi et al., 2015). The most well-known RND efflux pump is the AcrAB-TolC system 
of E.coli (Nikaido and Takatsuka, 2009). 
 
MFS family 
The MFS was originally believed to function primarily in the uptake of sugars (Henderson 
and Maiden, 1990). Subsequent studies revealed that the MFS family includes uptake or 
efflux systems for drugs, neurotransmitters, carboxylates, amino acids, osmolites, iron-
siderophores, and nucleosides. Several sub-families have been implicated in drug efflux, in 
particular, the DHA12 and DHA14 families, which consist of proton-driven drug and 
multidrug efflux proteins (Paulsen et al., 2001). Members of these two families possess either 
twelve or fourteen transmembrane segments, respectively (Paulsen and Skurray, 1993), and 
include well characterized members such as Bmr from Bacillus subtilis and QacA from 
Staphylococcus aureus. A member of MFS family called Metabolite-H+- 
Symporter (MHS) was found in Haloarcula marismortui and successfully expressed in E. coli 
(Ma et al., 2013).  
 
ABC family 
The number of ABC transporters differs widely between species. For example, almost 70 
ABC proteins are codified in Escherichia coli, while other species present a few types 
(Higgins, 2001). It is remarkable to know that there is an ABC transporter for almost all 
compounds that must pass the cellular membrane, that leads to a variety of different structures 
of these transporters depending on the substrate they bind to. As a consequence, the substrate 
specificity depends on the physiological role of each ABC protein. However, the minimal 
structural organization of an ABC transporter is the presence of four domains, i.e., two 
nucleotide binding domains (NBDs) and two transmembrane permease domains (TMDs) 
(Lubelski et al., 2007). ABC transporters are present also in halophilic archaea (Konings et 
al., 2002), and in particular a transporter for corrinoids belonging to this family was found in 
Halobacterium salinarum NRC-1 (Woodson et al., 2005). 
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SMR family 
The SMR family consists of a number of small, homologous proteins, ranging in size from 
104 to 115 amino acyl residues. SMRs facilitate the removal of a broad variety of cationic 
sanitizing agents, dyes, and antibiotics from the bacterial cell through use of the proton 
motive force (Poulsen et al., 2011). The best characterized members of this family are the 
SMR protein of S. aureus, known as QacC, Smr and Ebr together with the E. coli one called 
Ebr, MvrC or EmrE (Paulsen et al., 1996). Interestingly, the first Smr in the archaeal 
kingdom, named Hsmr, has been found in Halobacterium salinarum. The Hsmr protein 
(shown in Figure 4A) presents many of the signature sequence elements of the SMR family. 
Moreover, it contains a high percentage of negative residues in the loops, characteristic of 
extreme halophiles. The gene encoding for Hsmr is very rich in GC (68% GC), whereas the 
percentage of coding GC in the H. salinarum genome is slightly lower (65%). At the amino 
acid level Hsmr shares 54% similarity and 43% identity with the EmrE protein. A simple 
comparison of the amino acid composition of Hsmr and EmrE reveals some striking 
differences, which are summarized in Figure 4B (Ninio and Schuldiner, 2003).  
 
Figure 4. Secondary structure and amino acid composition of Hsmr. A, model of secondary structure 
of Hsmr based on hydropathy calculations and on analogy to EmrE. Putative transmembrane helices 
are shown as grey cylinders. Positive charged residues are highlighted, and negative charged are 
marked in black circles. B, the number of selected residues is given for EmrE (of a total of 110) and 
Hsmr (112) (Ninio and Schuldiner, 2003). 
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MATE family 
The drug efflux pumps of the MATE family represent an important bacterial antimicrobial 
agent resistance mechanism. Although the length of proteins in the MATE family ranges from 
400 to 700 amino acids, most members consist of 400–550 residues with 12 transmembrane 
helices. No apparent consensus sequence is conserved in all MATE proteins; however, these 
transporters are conserved in the three primary domains of life (Archaea, Bacteria and 
Eukarya), (Tanaka et al., 2013) and all MATE proteins share 40% sequence similarity (Omote 
et al., 2006). In general, almost all MATE family transporters can recognize fluoroquinolones 
as transport substrates, such as norfloxacin. Among cationic dyes, MATE transporters pump 
out acriflavine and ethidium bromide. It should be noted that aminoglycosides (especially 
kanamycin and streptomycin) might be good substrates (Kuroda and Tsuchiya, 2009). As a 
consequence, MATE-type transporters confer drug resistance for cationic drugs such as 
ethidium bromide (EtBr), tetraphenylphosphonium, berberine, acriflavine and norfloxacin 
(Omote et al., 2006). As concern the Archaea domain, the most well characterized member of 
the MATE family belongs to Pyrococcus furiosus, a member of the Euryarcheota phylum 
(Tanaka et al., 2013). 
 
Methodologies for studying antibiotic resistance in bacteria 
Basically the antibiotic resistance profile of a microorganism can be evaluated using two 
kinds of methods: phenotypic and genetic methods.  
Conventional methods involve the isolation of the bacterium of interest from the various 
environments taken into consideration. Then the microorganism is exposed to different 
concentrations of the selected antimicrobial substance and the Minimal Inhibitory 
Concentration (MIC), that is the lowest concentration of a chemical that prevents visible 
growth of a bacterium, is defined. Methods that are frequently used for testing cultivated 
bacteria and yeasts include disk diffusion, broth dilution, agar dilution, and gradient diffusion 
(Epsilometer test). American approved standards are provided by the Clinical and Laboratory 
Standards Institute (CLSI). 
Also genetic methods are very widespread. They assess the genotype of the microorganism, 
while with conventional methods the phenotype is determined. Secondly, they are more rapid 
than conventional ones because they don’t need the cultivation of the microorganism and they 
can be applied also to microorganisms difficult to cultivate or not cultivable. Finally they are 
less dangerous if the microorganism that has to be tested is a human pathogen.  
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The other side of the coin is that different assays have to be performed for each compound 
tested. Then, while with conventional methods all the mechanisms involved in the resistance 
against an antibiotic are checked at the same time, genetic methods detect only one specific 
mechanism at a time. This is the reason why culture based methods are useful for detecting 
emerging or new forms of antimicrobial resistance. Moreover, for some antibiotics the 
specific resistance mechanism is not clearly known, so it is no possible to detect this with 
genetic methods. Finally, unlike for conventional culture-based susceptibility test methods, no 
standards exist for performing genetic testing methods (Cockerill, 1999). 
 
Halophilic archaea along the food chain 
Halophilic archaea are a class of microorganisms belonging to the domain of Archaea. They 
require NaCl concentration of at least 1.5 M for proliferation, with optimal growth observed at 
3.5–4.5 M (Dyall-Smith, 2008; Oren et al., 1997). Its members are found ubiquitously in 
environments containing sodium chloride concentrations up to saturation (Pfeifer, 2015), such 
as solar salterns (Manikandan et al., 2009; Pasić et al., 2005) and soda lakes (Corral et al., 
2015).  
In the last decade, these microorganisms have raised an increasing scientific interest among 
food microbiologists, since they have been found along the food chain both with culture 
dependent and independent methods (Lee, 2013). In particular they have been found in salt-
fermented seafood (Roh et al., 2010, 2009, 2007a, 2007b; Roh and Bae, 2009), fish sauce 
(Tapingkae et al., 2008) and commercial salt (Henriet et al., 2014; Shimane et al., 2011; 
Shimoshige et al., 2013). 
 
Archaea occurrence in human gastrointestinal tract 
Archaea are naturally occurring components of the human and animal gut microbiota. The 
most abundant are methanogens and in particular Methanobrevibacter smithii and 
Methanosphaera stadmanae (Chaudhary et al., 2015). For this reason, it is not a coincidence 
that M. smithii was the first methanogen isolated from human stool (Nottingham and Hungate, 
1968), even if it was identified as archaeon only 15 years later (Lurie-Weinberger and 
Gophna, 2015). In the gastrointestinal tract, methanogens are the main actors in the process of 
methanogenesis (Vanderhaeghen et al., 2015), but they seem to take part also in pathogenic 
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processes (Pimentel et al., 2012), and in particular they may be involved in inflammatory 
bowel diseases (Blais Lecours et al., 2014; Ge et al., 2015). 
Another class found in the human gastrointestinal tract are halophilic archaea. Indeed they 
have been detected in human intestinal mucosa (Nkamga et al., 2017; Oxley et al., 2010) and 
in human stools (Khelaifia and Raoult, 2016) (Figure 5). In addition to metagenomic 
evidences, a recent study succeeded in isolating two halophilic archaea, Haloferax 
alexandrinus and Haloferax massiliensis, from human stool samples, confirming the effective 
presence of these microorganisms in the human gut (Lagier et al., 2016). However, their 
possible role in this environment has not yet been deeply investigated. 
 
 
Figure 5. Overview of the Archaea detected and isolated in the human gastrointestinal tract (Nkamga 
et al., 2017). URMITE stands for Unité de recherche sur les maladies infectieuses et tropicales 
émergentes. 
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Antibiotic resistance studies in halophilic archaea  
When firstly isolated, halophilic archaea were studied particularly for their exceptional ability 
to cope with high salt concentrations. For this reason the initial interest of scientists was 
aimed at understanding the mechanisms regulating such ability (Rodriguez-Valera, 1991). 
However, since the earlies 1980s, antibiotic resistance studies on these microorganisms 
started mainly for obtaining antibiotic-resistant mutants serving as genetic markers (Bonelo et 
al., 1984). The 1980s-1990s was the period when the majority of the studies were conducted: 
Pecher and Böck (1981) showed the insensitivity of H. salinarum to many protein synthesis 
inhibitors both of 70S and 80S ribosomes; Hilpert and collegues (1981) investigated nine 
strains of halophilic archaea assessing their insensitivity to the majority of antibiotics acting 
against Eubacteria and Eukaryotes; Forterre and collegues (1984) demonstrated the inhibition 
of halophilic archaea growth by aphidicolin, an antibiotic targeting eukaryotic α DNA 
polymerase; Hummel and Bock (1987) studied some mutations in H. salinarum 23S 
ribosomal RNA conferring resistance to anisomycin, Mankin and Garrett (1991) the H. 
salinarum (formerly H. halobium) mutations in the same gene conferring resistance to 
chloramphenicol while Holmes and Dyall-Smith (1991) the mutations in the DNA gyrase of 
two Haloferax strains conferring resistance to novobiocin; Nieto and collegues (1993) took in 
consideration 24 extremely halophilic archaea tested against 22 antimicrobial compounds in 
order to find antimicrobial resistance to use as genetic marker; Oren (1996) assessed the 
sensitivity of selected members of the family Halobacteriaceae to quinolone antibiotics. 
In the following years the interest was not completely vanished (Ghosh et al., 2010; Shinde 
and Thombre, 2016) but sensibly decreased.  
However, since up to now there is not a standardized method to assess the minimal inhibitory 
concentrations (MIC) in halophilic archaea, different methodologies were used, so MIC 
values of all these works cannot be compared. In addition, none of the works present in 
literature take in consideration at least 50 different strains of the same species of halophilic 
archaea, so the found values cannot be considered statistically significant. 
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